Fig. 2
From: The genetic and pharmacogenomic landscape of snoRNAs in human cancer
Pharmacogenomic landscape of snoRNAs. a Sample size included and significant snoRNA–drug pairs identified. b Association between snoRNA expression and imputed drug response. c Enrichment of various drug target pathways of significant snoRNA–drug response pairs. d Significantly correlated snoRNA–drug response pairs identified in PRAD. Drugs significantly associated with at least 5 snoRNAs are shown in the plot. e Association between SNORA23 expression and response to the drug axitinib in PAAD patients